<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Finasteride</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Finasteride">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Finasteride</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Finasteride</b>, sold under the brand names <b>Proscar</b> and <b>Propecia</b>, among others, is a medication mainly used to treat an enlarged prostate or hair loss in men.<span class="mw-ref" id="cite_ref-AHFS2019_2-0"><a href="#cite_note-AHFS2019-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It can also be used to treat excessive hair growth in women and as a part of hormone therapy for transgender women.<span class="mw-ref" id="cite_ref-Blume-PeytaviWhiting2008_3-0"><a href="#cite_note-Blume-PeytaviWhiting2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-TranssexualMgmnt2012_4-0"><a href="#cite_note-TranssexualMgmnt2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_2-1"><a href="#cite_note-AHFS2019-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Finasteride</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Finasteride.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Finasteride.svg.png" data-file-width="404" data-file-height="374" data-file-type="drawing" height="185" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Finasteride-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Finasteride-3D-balls.png" data-file-width="1100" data-file-height="598" data-file-type="bitmap" height="136" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Proscar, Propecia, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>MK-906; YM-152; L-652,931; 17β-(<i>N</i>-tert-Butylcarbamoyl)-4-aza-5α-androst-1-en-3-one; <i>N</i>-(1,1-Dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/finasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/finasteride.html'" tppabs="https://www.drugs.com/monograph/finasteride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a698016.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a698016.html'" tppabs="https://medlineplus.gov/druginfo/meds/a698016.html" class="external text external">a698016</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Finasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Finasteride'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Finasteride" class="external text external">Finasteride</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>X (will cause birth defects)</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>5α-Reductase inhibitor</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G04CB01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G04CB01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G04CB01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G04CB01" class="external text external">WHO</a></span>)<span> </span>D11AX10<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=D11AX10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=D11AX10'" tppabs="https://www.whocc.no/atc_ddd_index/?code=D11AX10" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>65%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-0"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>90%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-1"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP3A4, ALDH)<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-2"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>Adults: 5–6 hours<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-3"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>Elderly: &gt;8 hours<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-4"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces: 57%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-5"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>Urine: 40%<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-6"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(1S,3aS,3bS,5aR,9aR,9bS,11aS)-<i>N</i>-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=98319-26-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=98319-26-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=98319-26-7" class="external text external">98319-26-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/57363  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/57363'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/57363" class="external text external">57363</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6818  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6818'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6818" class="external text external">6818</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01216'" tppabs="https://www.drugbank.ca/drugs/DB01216" class="external text external">DB01216</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.51714.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.51714.html'" tppabs="http://www.chemspider.com/Chemical-Structure.51714.html" class="external text external">51714</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=57GNO57U7G  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=57GNO57U7G'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=57GNO57U7G" class="external text external">57GNO57U7G</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00321'" tppabs="https://www.kegg.jp/entry/D00321" class="external text external">D00321</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:5062  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:5062'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:5062" class="external text external">CHEBI:5062</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL710  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL710'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL710" class="external text external">ChEMBL710</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3020625  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3020625'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3020625" class="external text external">DTXSID3020625</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.149.445  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.149.445'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.149.445" class="external text external">100.149.445</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>23</sub><span>H</span><sub>36</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">372.553</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NC%28C%29%28C%29C%29%5BC%40%40H%5D2%5BC%40%5D1%28CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC2%29CC%5BC%40H%5D4NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D34C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NC%28C%29%28C%29C%29%5BC%40%40H%5D2%5BC%40%5D1%28CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC2%29CC%5BC%40H%5D4NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D34C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NC%28C%29%28C%29C%29%5BC%40%40H%5D2%5BC%40%5D1%28CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC2%29CC%5BC%40H%5D4NC%28%3DO%29%5CC%3DC%2F%5BC%40%5D34C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(NC(C)(C)C)[C@@H]2[C@]1(CC[C@H]3[C@H]([C@@H]1CC2)CC[C@H]4NC(=O)\C=C/[C@]34C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:DBEPLOCGEIEOCV-WSBQPABSSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458461973&page2=Finasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458461973&page2=Finasteride'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458461973&page2=Finasteride" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Finasteride is a 5α-reductase inhibitor and therefore an antiandrogen.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It works by decreasing the production of <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT) by about 70%, including in the prostate gland and the scalp.<span class="mw-ref" id="cite_ref-AHFS2019_2-2"><a href="#cite_note-AHFS2019-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


<p>Side effects from finasteride are rare,<span class="mw-ref" id="cite_ref-Cochrane2010_6-0"><a href="#cite_note-Cochrane2010-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> however some men experience sexual dysfunction, depression, and breast enlargement.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-2014AArev_8-0"><a href="#cite_note-2014AArev-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> In some men, sexual dysfunction may persist after stopping the medication.<span class="mw-ref" id="cite_ref-Zax2019_9-0"><a href="#cite_note-Zax2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Tra2020_10-0"><a href="#cite_note-Tra2020-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It may also increase the risk of certain forms of prostate cancer.<span class="mw-ref" id="cite_ref-2014AArev_8-1"><a href="#cite_note-2014AArev-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


<p>Finasteride was patented in 1984 and approved for medical use in 1992.<span class="mw-ref" id="cite_ref-Fis2006_11-0"><a href="#cite_note-Fis2006-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-SataloffSclafani2015_12-0"><a href="#cite_note-SataloffSclafani2015-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> A month supply in the United Kingdom costs the NHS about £0.89 per month as of 2019.<span class="mw-ref" id="cite_ref-BNF76_13-0"><a href="#cite_note-BNF76-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> In the United States, the wholesale cost of this amount is about US$2.34.<span class="mw-ref" id="cite_ref-NADAC2019_14-0"><a href="#cite_note-NADAC2019-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> In 2017, it was the 86th-most commonly prescribed medication in the United States, with more than nine million prescriptions.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Enlarged_prostate">Enlarged prostate</h3></summary>
    
<p>Physicians sometimes prescribe finasteride for the treatment of benign prostatic hyperplasia (BPH), informally known as an enlarged prostate. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start and end of urination, and decreased urinary flow. It provides less symptomatic relief than alpha-1 blockers such as <a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">tamsulosin</a> and symptomatic relief is slower in onset (six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment). Symptomatic benefits are mainly seen in those with prostate volume &gt; 40<span>&nbsp;</span>cm<sup>3</sup>. In long-term studies finasteride but not alpha-1 inhibitors reduce the risk of acute urinary retention (−57% at 4 years) and the need for surgery (−54% at 4 years). If the drug is discontinued, any therapeutic benefits are reversed within about 6–8 months.<span class="mw-ref" id="cite_ref-ProscarLabel_17-0"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Cochrane2010_6-1"><a href="#cite_note-Cochrane2010-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Scalp_hair_loss">Scalp hair loss</h3></summary>
    
<p>Finasteride is also used to treat male pattern baldness (androgenic alopecia) in men, a condition that develops in up to 80% of Caucasian men.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-PropeciaLabel_19-0"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> In the United States, finasteride and <a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">minoxidil</a> are the only two FDA approved drugs for the treatment of male pattern hair loss as of 2017.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Treatment with finasteride slows further hair loss<span class="mw-ref" id="cite_ref-Habif2015_21-0"><a href="#cite_note-Habif2015-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> and provides about 30% improvement in hair loss after six months of treatment, with effectiveness persisting as long as the drug is taken.<span class="mw-ref" id="cite_ref-2014AArev_8-2"><a href="#cite_note-2014AArev-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Taking finasteride leads to a reduction in scalp and serum DHT levels; by lowering scalp levels of DHT, finasteride can maintain or increase the amount of terminal hairs in the anagen phase by inhibiting and sometimes reversing miniaturization of the hair follicle. Finasteride is most effective on the vertex but can reduce hair loss in all areas of the scalp.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Finasteride has also been tested for pattern hair loss in women; however, the results were no better than placebo.<span class="mw-ref" id="cite_ref-FPArev_24-0"><a href="#cite_note-FPArev-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Prostate_cancer">Prostate cancer</h3></summary>
    
<p>In males over 55 years old finasteride decreases the risk of low grade prostate cancer but may increase the risk of high grade prostate cancer and has no effect on overall survival.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>A 2010 review found a 25% reduction in the risk of prostate cancer with 5α-reductase inhibitor.<span class="mw-ref" id="cite_ref-pmid20977593_26-0"><a href="#cite_note-pmid20977593-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> A follow-up study of the Medicare claims of participants in a 10-year Prostate Cancer Prevention Trial suggests the reduction in prostate cancer is maintained even after discontinuation of treatment.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> However, 5α-reductase inhibitors have been found to increase the risk of developing certain rare but aggressive forms of prostate cancer (27% risk increase), although not all studies have observed this.<span class="mw-ref" id="cite_ref-Hirshburg2016_28-0"><a href="#cite_note-Hirshburg2016-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> No impact of 5-α-reductase inhibitor on survival has been found in people with prostate cancer.<span class="mw-ref" id="cite_ref-Hirshburg2016_28-1"><a href="#cite_note-Hirshburg2016-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Excessive_hair_growth">Excessive hair growth</h4></summary>
    
<p>Finasteride has been found to be effective in the treatment of hirsutism (excessive facial and/or body hair growth) in women. In a study of 89 women with hyperandrogenism due to persistent adrenarche syndrome, finasteride produced a 93% reduction in facial hirsutism and a 73% reduction bodily hirsutism after 2 years of treatment. Other studies using finasteride for hirsutism have also found it to be clearly effective.<span class="mw-ref" id="cite_ref-Blume-PeytaviWhiting2008_3-1"><a href="#cite_note-Blume-PeytaviWhiting2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Transgender_hormone_therapy">Transgender hormone therapy</h3></summary>
    
<p>Finasteride is sometimes used in hormone replacement therapy for transgender women due to its antiandrogenic effects, in combination with a form of estrogen. However, little clinical research of finasteride use for this purpose has been conducted and evidence of safety or efficacy is limited.<span class="mw-ref" id="cite_ref-TranssexualMgmnt2012_4-1"><a href="#cite_note-TranssexualMgmnt2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Moreover, caution has been recommended when prescribing finasteride to transgender women, as finasteride may be associated with side effects such as depression, anxiety, and suicidal ideation, symptoms that are particularly prevalent in the transgender population and in others at high risk already.<span class="mw-ref" id="cite_ref-Trüeb2017_29-0"><a href="#cite_note-Trüeb2017-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>A 2010 Cochrane review concluded that adverse effects from finasteride are rare when used for BPH.<span class="mw-ref" id="cite_ref-Cochrane2010_6-2"><a href="#cite_note-Cochrane2010-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> When finasteride was originally approved for hair loss in 1997, the FDA reported that it appeared well tolerated, with the most common side effects being related to sexual function.<span class="mw-ref" id="cite_ref-FDA1997_30-0"><a href="#cite_note-FDA1997-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Finasteride is contraindicated in pregnancy.<span class="mw-ref" id="cite_ref-:0_31-0"><a href="#cite_note-:0-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> The Food and Drug Administration advises that donation of blood or plasma be deferred for at least one month after taking the last dose of finasteride.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>

<p>The FDA has added a warning to 5α-reductase inhibitors concerning an increased risk of high-grade prostate cancer, as the treatment of BPH lowers PSA (prostate-specific antigen), which could mask the development of prostate cancer.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid20357287_35-0"><a href="#cite_note-pmid20357287-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> Although overall incidence of male breast cancer in clinical trials for finasteride 5<span>&nbsp;</span>mg was not increased, there are post-marketing reports of breast cancer in association with its use, though available evidence does not provide clarity as to whether there is a causative relationship between finasteride and these cancers.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-1"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> A 2018 meta-analysis found no higher risk of breast cancer with 5α-reductase inhibitors.<span class="mw-ref" id="cite_ref-pmid29697934_37-0"><a href="#cite_note-pmid29697934-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Some men develop gynecomastia (breast development or enlargement) following finasteride usage.<span class="mw-ref" id="cite_ref-Narula2014_38-0"><a href="#cite_note-Narula2014-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Drugs_39-0"><a href="#cite_note-Drugs-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-Bolignano2014_40-0"><a href="#cite_note-Bolignano2014-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> The risk of gynecomastia with 5α-reductase inhibitors is low at about 1.5%.<span class="mw-ref" id="cite_ref-pmid27784557_42-0"><a href="#cite_note-pmid27784557-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Depressive symptoms and suicidality have been reported.<span class="mw-ref" id="cite_ref-pmid28456011_43-0"><a href="#cite_note-pmid28456011-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sexual_dysfunction">Sexual dysfunction</h3></summary>
    
<p>Finasteride causes short-term sexual dysfunction in some men, which may persist in some men after stopping the medication.<span class="mw-ref" id="cite_ref-Zax2019_9-1"><a href="#cite_note-Zax2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Tra2020_10-1"><a href="#cite_note-Tra2020-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> There are case reports of persistent diminished libido or erectile dysfunction after stopping the drug and the FDA has updated the label to inform people of these reports.<span class="mw-ref" id="cite_ref-2014AArev_8-3"><a href="#cite_note-2014AArev-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-pmid27784557_42-1"><a href="#cite_note-pmid27784557-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>The 2010 Cochrane review found that compared with placebo, men taking finasteride are at increased risk for impotence, erectile dysfunction, decreased libido, and ejaculation disorder for the first year of treatment. The risk of side effects were dose dependent, with a higher risk for men taking 5<span>&nbsp;</span>mg in comparison to 1<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> The rates also became indistinguishable from placebo after 2–4 years and these side effects usually got better over time.<span class="mw-ref" id="cite_ref-Cochrane2010_6-3"><a href="#cite_note-Cochrane2010-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Mella_JM_2010_46-0"><a href="#cite_note-Mella_JM_2010-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> A 2016 meta-analysis found that sexual dysfunction, including erectile dysfunction, loss of libido, and reduced ejaculate, may occur in 3.4 to 15.8% of men treated with finasteride or dutasteride.<span class="mw-ref" id="cite_ref-Hirshburg2016_28-2"><a href="#cite_note-Hirshburg2016-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> This adverse effect has been linked to lower quality of life and can cause stress in relationships.<span class="mw-ref" id="cite_ref-Gur2013_47-0"><a href="#cite_note-Gur2013-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Long-term">Long-term</h3></summary>
    
<p>Finasteride may cause persistent adverse sexual, neurological and physical effects in a subset of men.<span class="mw-ref" id="cite_ref-Zax2019_9-2"><a href="#cite_note-Zax2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Tra2020_10-2"><a href="#cite_note-Tra2020-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> This has been called post-finasteride syndrome, characterized by reported sexual and physical symptoms such as loss of libidio, erectile dysfunction, ejaculatory disorders, reduction in penis size, penile curvature, reduced sensation, male breast enlargement, muscular atrophy, fatigue and severely dry skin. People with post-finasteride syndrome may experience depression and anxiety, cognitive impairment and suicidal thoughts.<span class="mw-ref" id="cite_ref-Tra2020_10-3"><a href="#cite_note-Tra2020-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Post-finasteride syndrome may also have reduced levels of neurosteroids such as allopregnanolone in their cerebrospinal fluid. One study found that 1.4% developed persistent sexual dysfunction.<span class="mw-ref" id="cite_ref-Zax2019_9-3"><a href="#cite_note-Zax2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>A 2019 Reuters investigation showed that Merck found evidence of persistent side effects in their original clinical trials and did not disclose it in their warning label.<span class="mw-ref" id="cite_ref-Reut2019a_48-0"><a href="#cite_note-Reut2019a-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-Reut2019pdf_49-0"><a href="#cite_note-Reut2019pdf-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> They uncovered court filings which demonstrated that Merck misrepresented Propecia's safety record following clinical trials in the mid-late 1990s.<span class="mw-ref" id="cite_ref-Reut2019a_48-1"><a href="#cite_note-Reut2019a-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>In one deposition, Charlotte Merritt, who oversaw regulatory activity for Propecia, acknowledged that Merck changed Propecia's label for sexual adverse events in 2002, four years after Propecia hit the market. The label changed from “resolution occurred in all men who discontinued therapy with Propecia ” to “resolution occurred in men who discontinued therapy with Propecia”. Merritt testified that Merck eliminated the word “all” due to evidence from the clinical trials of adverse events that did not resolve following discontinuation of use.<span class="mw-ref" id="cite_ref-Reut2019pdf_49-1"><a href="#cite_note-Reut2019pdf-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> In another deposition, Paul Howes, the head of marketing for Propecia acknowledged that Merck was aware that warnings of sexual side effects, particularly persistent to permanent side effects, would have a devastating impact on sales.<span class="mw-ref" id="cite_ref-Reut2019pdf_49-2"><a href="#cite_note-Reut2019pdf-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Finasteride has been studied in humans at single doses of up to 400<span>&nbsp;</span>mg and at continuous dosages of up to 80<span>&nbsp;</span>mg/day for three months, without adverse effects observed.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-2"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-ProscarLabel_17-1"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-pmid16719800_50-0"><a href="#cite_note-pmid16719800-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> These doses are many times in excess of the typical dosages of finasteride of 1<span>&nbsp;</span>mg/day and 5<span>&nbsp;</span>mg/day that are used clinically.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-3"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-ProscarLabel_17-2"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> There is no specific recommended antidote for finasteride overdose.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-4"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-ProscarLabel_17-3"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>No significant drug interactions have been observed between finasteride and a limited selection of medications.<span class="mw-ref" id="cite_ref-pmid7689728_51-0"><a href="#cite_note-pmid7689728-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Finasteride is a 5α-reductase inhibitor.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-5"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-7"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is specifically a selective inhibitor of the type II and III isoforms of the enzyme.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-8"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Yamana2010_52-0"><a href="#cite_note-Yamana2010-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid19879888_53-0"><a href="#cite_note-pmid19879888-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> By inhibiting these two isozymes of 5α-reductase, finasteride reduces the formation of the potent androgen <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT) from its precursor <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> in certain tissues in the body such as the prostate gland, skin, and hair follicles.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-9"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Azz_54-0"><a href="#cite_note-Azz-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> As such, finasteride is a type of antiandrogen, or more specifically, an androgen synthesis inhibitor.<span class="mw-ref" id="cite_ref-Preedy2012_55-0"><a href="#cite_note-Preedy2012-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-Wu2012_56-0"><a href="#cite_note-Wu2012-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> However, some authors do not define finasteride as an "antiandrogen," a term which can refer more specifically to antagonists of the androgen receptor.<span class="mw-ref" id="cite_ref-ClapauchWeiss2017_57-0"><a href="#cite_note-ClapauchWeiss2017-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span></p>

<p>Finasteride results in a decrease of circulating DHT levels by about 65 to 70% with an oral dosage of 5<span>&nbsp;</span>mg/day and of DHT levels in the prostate gland by up to 80 to 90% with an oral dosage of 1 or 5<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-Yamana2010_52-1"><a href="#cite_note-Yamana2010-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid10765065_58-0"><a href="#cite_note-pmid10765065-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid29379733_59-0"><a href="#cite_note-pmid29379733-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> In parallel, circulating levels of testosterone increase by approximately 10%, while local concentrations of testosterone in the prostate gland increase by about 7-fold and local testosterone levels in hair follicles increase by around 27 to 53%.<span class="mw-ref" id="cite_ref-pmid7505051_60-0"><a href="#cite_note-pmid7505051-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-pmid15102575_61-0"><a href="#cite_note-pmid15102575-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> An oral dosage of finasteride of only 0.2<span>&nbsp;</span>mg/day has been found to achieve near-maximal suppression of DHT levels (68.6% for 0.2<span>&nbsp;</span>mg/day relative to 72.2% for 5<span>&nbsp;</span>mg/day).<span class="mw-ref" id="cite_ref-pmid15102575_61-1"><a href="#cite_note-pmid15102575-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-pmid12894990_62-0"><a href="#cite_note-pmid12894990-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Finasteride does not completely suppress DHT production because it lacks significant inhibitory effects on the 5α-reductase type I isoenzyme, with more than 100-fold less inhibitory potency for type I as compared to type II (<abbr>IC<sub>50</sub></abbr> = 313<span>&nbsp;</span>nM and 11<span>&nbsp;</span>nM, respectively).<span class="mw-ref" id="cite_ref-PropeciaLabel_19-6"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-10"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This is in contrast to inhibitors of all three isoenzymes of 5α-reductase like <a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">dutasteride</a>, which can reduce DHT levels in the entire body by more than 99%.<span class="mw-ref" id="cite_ref-Yamana2010_52-2"><a href="#cite_note-Yamana2010-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In addition to inhibiting 5α-reductase, finasteride has also been found to competitively inhibit 5β-reductase (AKR1D1).<span class="mw-ref" id="cite_ref-pmid19515843_63-0"><a href="#cite_note-pmid19515843-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> However, its affinity for the enzyme is substantially less than for 5α-reductase (an order of magnitude less than for 5α-reductase <i>type I</i>) and hence is unlikely to be of clinical significance.<span class="mw-ref" id="cite_ref-pmid19515843_63-1"><a href="#cite_note-pmid19515843-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>

<p>As of 2012, the tissues in which the different isozymes of 5α-reductase are expressed are not fully clear.<span class="mw-ref" id="cite_ref-Azz_54-1"><a href="#cite_note-Azz-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> This is because different investigators have obtained varying results with different reagents, methods, and tissues examined.<span class="mw-ref" id="cite_ref-Azz_54-2"><a href="#cite_note-Azz-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> However, the different isozymes of 5α-reductase appear to be widely expressed, with notable tissues including the prostate gland, seminal vesicles, testes, epididymides, skin, hair follicles, liver, kidneys, and brain, among others.<span class="mw-ref" id="cite_ref-Azz_54-3"><a href="#cite_note-Azz-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>

<p>By inhibiting 5α-reductase and thus preventing DHT production, finasteride reduces androgen signaling in tissues like the prostate gland and the scalp. In the prostate, this reduces prostate volume, which improves BPH and reduces risk of prostate cancer. Finasteride reduces prostate volume by 20 to 30% in men with benign prostatic hyperplasia.<span class="mw-ref" id="cite_ref-BostwickCheng2014_64-0"><a href="#cite_note-BostwickCheng2014-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Inhibition of 5α-reductase also reduces epididymal weight, and decreases motility and normal morphology of spermatozoa in the epididymis.<span class="mw-ref" id="cite_ref-pmid16476520_65-0"><a href="#cite_note-pmid16476520-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>

<p>Neurosteroids like 3α-androstanediol (derived from DHT) and <a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">allopregnanolone</a> (derived from <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>) activate the GABA<sub>A</sub> receptor in the brain; because finasteride prevents the formation of neurosteroids, it functions as a neurosteroidogenesis inhibitor and may contribute to a reduction of GABA<sub>A</sub> activity. Reduction of GABA<sub>A</sub> receptor activation by these neurosteroids has been implicated in depression, anxiety, and sexual dysfunction.<span class="mw-ref" id="cite_ref-pmid16834758_66-0"><a href="#cite_note-pmid16834758-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-pmid21122055_67-0"><a href="#cite_note-pmid21122055-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-pmid22164129_68-0"><a href="#cite_note-pmid22164129-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>The mean oral bioavailability of finasteride is approximately 65%.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-11"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The absorption of finasteride is not affected by food.<span class="mw-ref" id="cite_ref-PropeciaLabel_19-7"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-ProscarLabel_17-4"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> At steady-state with 1<span>&nbsp;</span>mg/day finasteride, mean peak concentrations of finasteride were 9.2<span>&nbsp;</span>ng/mL (25<span>&nbsp;</span>nmol/L).<span class="mw-ref" id="cite_ref-PropeciaLabel_19-8"><a href="#cite_note-PropeciaLabel-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Conversely, following a single 5<span>&nbsp;</span>mg dose of finasteride, mean peak levels of finasteride were 37<span>&nbsp;</span>ng/mL (99<span>&nbsp;</span>nmol/L), and plasma concentrations increased by 47 to 54% following 2.5<span>&nbsp;</span>weeks of continued daily administration.<span class="mw-ref" id="cite_ref-ProscarLabel_17-5"><a href="#cite_note-ProscarLabel-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The volume of distribution of finasteride is 76<span>&nbsp;</span>L.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-12"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Its plasma protein binding is 90%.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-13"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The drug has been found to cross the blood–brain barrier, whereas levels in semen were found to be undetectable.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-14"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>Finasteride is extensively metabolized in the liver, first by hydroxylation via CYP3A4 and then by aldehyde dehydrogenase.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-15"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It has two major metabolites, which are the <i>tert</i>-butyl side chain monohydroxylated and monocarboxylic acid metabolites.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-16"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> These metabolites show approximately 20% of the inhibitory activity of finasteride on 5α-reductase.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-17"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Hence, the metabolites of finasteride are not particularly active.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-18"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The drug has a terminal half-life of 5 to 6<span>&nbsp;</span>hours in adult men (18–60<span>&nbsp;</span>years of age) and a terminal half-life of 8<span>&nbsp;</span>hours or more in elderly men (more than 70<span>&nbsp;</span>years of age).<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-19"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is eliminated as its metabolites 57% in the feces and 40% in the urine.<span class="mw-ref" id="cite_ref-LemkeWilliams2008_1-20"><a href="#cite_note-LemkeWilliams2008-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


<p>Finasteride, also known as 17β-(<i>N</i>-tert-butylcarbamoyl)-4-aza-5α-androst-1-en-3-one, is a synthetic <a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/Androstane" title="Androstane">androstane</a> steroid and 4-azasteroid.<span class="mw-ref" id="cite_ref-pmid7689728_51-1"><a href="#cite_note-pmid7689728-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-pmid8117686_69-0"><a href="#cite_note-pmid8117686-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> It is an analogue of androgen steroid hormones like testosterone and DHT.<span class="mw-ref" id="cite_ref-pmid7689728_51-2"><a href="#cite_note-pmid7689728-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> As an unconjugated steroid, finasteride is a highly lipophilic compound.<span class="mw-ref" id="cite_ref-pmid7689728_51-3"><a href="#cite_note-pmid7689728-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-micro_70-0"><a href="#cite_note-micro-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>In 1942, James Hamilton observed that prepubertal castration prevents the later development of male pattern baldness in mature men.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> In 1974, Julianne Imperato-McGinley of Cornell Medical College in New York attended a conference on birth defects. She reported on a group of intersex children in the Caribbean who appeared sexually ambiguous at birth, and were initially raised as girls, but then grew external male genitalia and other masculine characteristic after onset of puberty. These children, despite being raised as girls until puberty, were generally heterosexual, and were termed "Guevedoces" by their local community, which means "penis at twelve" in Spanish.<span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> Her research group found these children shared a genetic mutation, causing deficiency of the 5α-reductase enzyme and male hormone <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT), which was found to have been the etiology behind abnormalities in male sexual development. Upon maturation, these individuals were observed to have smaller prostates which were underdeveloped, and were also observed to lack incidence of male pattern baldness.<span class="mw-ref" id="cite_ref-pmid4432067_73-0"><a href="#cite_note-pmid4432067-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span><span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>

<p>In 1975, copies of Imperato-McGinley's presentation were seen by P. Roy Vagelos, who was then serving as Merck's basic-research chief. He was intrigued by the notion that decreased levels of DHT led to the development of smaller prostates. Dr. Vagelos then sought to create a drug which could mimic the condition found in these children to treat older men who were suffering from benign prostatic hyperplasia.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>

<p>Finasteride was developed by Merck under the code name MK-906.<span class="mw-ref" id="cite_ref-pmid7689728_51-4"><a href="#cite_note-pmid7689728-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span>  A team led by chemist Gary Rasmusson and biologist Jerry Brooks developed potential 5α-reductase inhibitors based on transition state inhibitors, using an iterative process of molecular design, testing, and redesign.<span class="mw-ref" id="cite_ref-Cordes2014_76-0"><a href="#cite_note-Cordes2014-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span>  In 1992, finasteride (5<span>&nbsp;</span>mg) was approved by the U.S. Food and Drug Administration (FDA) for treatment of BPH, which Merck marketed under the brand name Proscar. Rasmusson and  Brooks were awarded IPO's “Inventor of the Year” award in 1993 for their work on finasteride.<span class="mw-ref" id="cite_ref-IPOInventor_77-0"><a href="#cite_note-IPOInventor-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span>  In 1997, Merck was successful in obtaining FDA approval for a second indication of finasteride (1<span>&nbsp;</span>mg) for treatment of male pattern hair loss, which was marketed under the brand name Propecia.<span class="mw-ref" id="cite_ref-BurgerAbraham2003_78-0"><a href="#cite_note-BurgerAbraham2003-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> It was the first 5α-reductase inhibitor to be introduced and was followed by <a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">dutasteride</a> in 2001.<span class="mw-ref" id="cite_ref-Doherty2003_79-0"><a href="#cite_note-Doherty2003-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> The first study of finasteride in the treatment of hirsutism in women was published in 1994.<span class="mw-ref" id="cite_ref-pmid9420861_80-0"><a href="#cite_note-pmid9420861-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Finasteride</i> is the generic name of the drug and its <abbr>INN</abbr>, <abbr>USAN</abbr>, <abbr>BAN</abbr>, and <abbr>JAN</abbr>, while <i>finastéride</i> is its <abbr>DCF</abbr>.<span class="mw-ref" id="cite_ref-IndexNominum2000_81-0"><a href="#cite_note-IndexNominum2000-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_82-0"><a href="#cite_note-MortonHall2012-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-BycroftPayne2013_83-0"><a href="#cite_note-BycroftPayne2013-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_84-0"><a href="#cite_note-Drugs.com-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> It is also known by its former developmental code names <i>MK-906</i>, <i>YM-152</i>, and <i>L-652,931</i>.<span class="mw-ref" id="cite_ref-IndexNominum2000_81-1"><a href="#cite_note-IndexNominum2000-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_82-1"><a href="#cite_note-MortonHall2012-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-BycroftPayne2013_83-1"><a href="#cite_note-BycroftPayne2013-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_84-1"><a href="#cite_note-Drugs.com-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Finasteride is marketed primarily under the brand names Propecia, for pattern hair loss, and Proscar, for BPH, both of which are products of Merck &amp; Co.<span class="mw-ref" id="cite_ref-Drugs.com_84-2"><a href="#cite_note-Drugs.com-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> There is 1<span>&nbsp;</span>mg of finasteride in Propecia and 5<span>&nbsp;</span>mg in Proscar. Merck's patent on finasteride for the treatment of BPH expired in June 2006.<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> Merck was awarded a separate patent for the use of finasteride to treat pattern hair loss and it expired in November 2013.<span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> Finasteride is also marketed under a variety of other brand names throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_84-3"><a href="#cite_note-Drugs.com-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Controversy">Controversy</h3></summary>
    
<p>Men in the U.S. and Canada concerned about persistent sexual side effects "coined the phrase 'post-finasteride syndrome', which they say is characterized by sexual, neurological, hormonal and psychological side effects that can persist in men who have taken finasteride for hair loss or an enlarged prostate".<span class="mw-ref" id="cite_ref-Margo_87-0"><a href="#cite_note-Margo-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> In 2016, Merck was a defendant in approximately 1,370 product liability lawsuits which had been filed by customers alleging they have experienced persistent sexual side effects following cessation of treatment with finasteride.<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Athletics">Athletics</h3></summary>
    
<p>From 2005 to 2009, the World Anti-Doping Agency banned finasteride because it was discovered that the drug could be used to mask steroid abuse.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> It was removed from the list effective January 1, 2009, after improvements in testing methods made the ban unnecessary.<span class="mw-ref" id="cite_ref-Australian_90-0"><a href="#cite_note-Australian-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Athletes who used finasteride and were banned from international competition include skeleton racer Zach Lund, bobsledder Sebastien Gattuso, footballer Romário, and ice hockey goaltender José Théodore.<span class="mw-ref" id="cite_ref-Australian_90-1"><a href="#cite_note-Australian-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Miscellaneous">Miscellaneous</h3></summary>
    
<p>The U.S. Food and Drug Administration advises that donation of blood or plasma be deferred for at least one month after taking the last dose of finasteride.<span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span> The UK also has a one-month deferral period.<span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span></p>

<p>Harold Bornstein, the former<span class="mw-ref" id="cite_ref-94"><a href="#cite_note-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> personal physician of United States President Donald Trump, stated in 2017 that Trump was taking finasteride to promote hair growth.<span class="mw-ref" id="cite_ref-95"><a href="#cite_note-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><span class="mw-ref" id="cite_ref-96"><a href="#cite_note-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Preliminary research suggests that topical finasteride may be effective in the treatment of pattern hair loss.<span class="mw-ref" id="cite_ref-pmid29601622_97-0"><a href="#cite_note-pmid29601622-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span><span class="mw-ref" id="cite_ref-pmid31832993_98-0"><a href="#cite_note-pmid31832993-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Topical finasteride, like the oral preparation, reduces serum DHT.<span class="mw-ref" id="cite_ref-pmid31832993_98-1"><a href="#cite_note-pmid31832993-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> However, studies have shown that the extent of the reduction of serum DHT is less with the topical application.</p>

<p>DHT may be involved in the cause of acne, and 5α-reductase inhibitors might be effective in the treatment of the condition.<span class="mw-ref" id="cite_ref-Danby2015_99-0"><a href="#cite_note-Danby2015-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span><span class="mw-ref" id="cite_ref-pmid23431485_100-0"><a href="#cite_note-pmid23431485-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> A small retrospective study reported that finasteride was effective in the treatment of acne in women with normal <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> levels.<span class="mw-ref" id="cite_ref-pmid30604525_101-0"><a href="#cite_note-pmid30604525-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span><span class="mw-ref" id="cite_ref-pmid23431485_100-1"><a href="#cite_note-pmid23431485-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> A randomized controlled trial found that finasteride was less effective than <a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">flutamide</a> or an ethinylestradiol/cyproterone acetate birth control pill in the treatment of acne in women with high androgen levels.<span class="mw-ref" id="cite_ref-pmid30604525_101-1"><a href="#cite_note-pmid30604525-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>

<p>Androgens and <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogens</a> may be involved in the cause of hidradenitis suppurativa (acne inversa).<span class="mw-ref" id="cite_ref-pmid19293006_102-0"><a href="#cite_note-pmid19293006-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span><span class="mw-ref" id="cite_ref-pmid28128074_103-0"><a href="#cite_note-pmid28128074-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> Two case series have reported that finasteride is effective in the treatment of hidradenitis suppurativa in girls and women.<span class="mw-ref" id="cite_ref-pmid30604525_101-2"><a href="#cite_note-pmid30604525-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-LemkeWilliams2008-1"> <span id="mw-reference-text-cite_note-LemkeWilliams2008-1" class="mw-reference-text"><cite id="CITEREFLemkeWilliams2008" class="citation book cs1">Lemke TL, Williams DA (2008). <a href="javascript:if(confirm('https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286'" tppabs="https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA1286" class="external text external"><i>Foye's Principles of Medicinal Chemistry</i></a> (6th ed.). Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>1286–. ISBN<span>&nbsp;</span><bdi>978-0-7817-6879-5</bdi>.</cite></span></li><li id="cite_note-AHFS2019-2"> <span id="mw-reference-text-cite_note-AHFS2019-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/finasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/finasteride.html'" tppabs="https://www.drugs.com/monograph/finasteride.html" class="external text external">"Finasteride Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">5 March</span> 2019</span>.</cite></span></li><li id="cite_note-Blume-PeytaviWhiting2008-3"> <span id="mw-reference-text-cite_note-Blume-PeytaviWhiting2008-3" class="mw-reference-text"><cite id="CITEREFBlume-PeytaviWhitingTrüeb2008" class="citation book cs1">Blume-Peytavi U, Whiting DA, Trüeb RM (26 June 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369'" tppabs="https://books.google.com/books?id=pHrX2-huQCoC&pg=PA369" class="external text external"><i>Hair Growth and Disorders</i></a>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>369. ISBN<span>&nbsp;</span><bdi>978-3-540-46911-7</bdi>.</cite></span></li><li id="cite_note-TranssexualMgmnt2012-4"> <span id="mw-reference-text-cite_note-TranssexualMgmnt2012-4" class="mw-reference-text"><cite id="CITEREFKnezevichViereckDrincic2012" class="citation journal cs1">Knezevich EL, Viereck LK, Drincic AT (January 2012). "Medical management of adult transsexual persons". <i>Pharmacotherapy</i>. <b>32</b> (1): 54–66. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2FPHAR.1006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2FPHAR.1006'" tppabs="https://doi.org/10.1002%2FPHAR.1006" class="external text external">10.1002/PHAR.1006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22392828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22392828'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22392828" class="external text external">22392828</a>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFFerri2014" class="citation book cs1">Ferri, Fred F. (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=icTsAwAAQBAJ&pg=PA580  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=icTsAwAAQBAJ&pg=PA580'" tppabs="https://books.google.com/books?id=icTsAwAAQBAJ&pg=PA580" class="external text external"><i>Ferri's Clinical Advisor 2015 E-Book: 5 Books in 1</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>580. ISBN<span>&nbsp;</span><bdi>9780323084307</bdi>.</cite></span></li><li id="cite_note-Cochrane2010-6"> <span id="mw-reference-text-cite_note-Cochrane2010-6" class="mw-reference-text"><cite id="CITEREFTacklindFinkMacdonaldRutks2010" class="citation journal cs1">Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ (October 2010). "Finasteride for benign prostatic hyperplasia". <i>The Cochrane Database of Systematic Reviews</i> (10): CD006015. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD006015.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD006015.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD006015.pub3" class="external text external">10.1002/14651858.CD006015.pub3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20927745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20927745'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20927745" class="external text external">20927745</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFZakhemGoldbergMotoskoCohen2019" class="citation journal cs1">Zakhem GA, Goldberg JE, Motosko CC, Cohen BE, Ho RS (1 July 2019). "Sexual dysfunction in men taking systemic dermatologic medication: A systematic review". <i>J Am Acad Dermatol</i>. <b>81</b> (1): 163–172. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2019.03.043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2019.03.043'" tppabs="https://doi.org/10.1016%2Fj.jaad.2019.03.043" class="external text external">10.1016/j.jaad.2019.03.043</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30905792  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30905792'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30905792" class="external text external">30905792</a>.</cite></span></li><li id="cite_note-2014AArev-8"> <span id="mw-reference-text-cite_note-2014AArev-8" class="mw-reference-text"><cite id="CITEREFVarothaiBergfeld2014" class="citation journal cs1">Varothai S, Bergfeld WF (July 2014). "Androgenetic alopecia: an evidence-based treatment update". <i>American Journal of Clinical Dermatology</i>. <b>15</b> (3): 217–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40257-014-0077-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40257-014-0077-5'" tppabs="https://doi.org/10.1007%2Fs40257-014-0077-5" class="external text external">10.1007/s40257-014-0077-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24848508  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24848508'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24848508" class="external text external">24848508</a>.</cite></span></li><li id="cite_note-Zax2019-9"> <span id="mw-reference-text-cite_note-Zax2019-9" class="mw-reference-text"><cite class="citation journal cs1">Zakhem, GA; Goldberg, JE; Motosko, CC; Cohen, BE; Ho, RS (July 2019). "Sexual dysfunction in men taking systemic dermatologic medication: A systematic review". <i>Journal of the American Academy of Dermatology</i>. <b>81</b> (1): 163–172. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2019.03.043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2019.03.043'" tppabs="https://doi.org/10.1016%2Fj.jaad.2019.03.043" class="external text external">10.1016/j.jaad.2019.03.043</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30905792  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30905792'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30905792" class="external text external">30905792</a>. <q>In studies addressing reversibility, most of these patients have resolution of sexual adverse effects after discontinuation of finasteride, and many have improvement of adverse effects over time with continued finasteride use. However, some studies CAPSULE SUMMARY d Prescription medications are a common cause of sexual dysfunction. Possible sexual adverse effects should be discussed with men using these medications. d We identified evidence for sexual adverse effects in patients taking 11 systemic dermatologic medications. Level 1 evidence evaluating sexual dysfunction as a primary outcome was available for finasteride.</q></cite></span></li><li id="cite_note-Tra2020-10"> <span id="mw-reference-text-cite_note-Tra2020-10" class="mw-reference-text"><cite id="CITEREFTraish2020" class="citation journal cs1">Traish, AM (January 2020). "Post-finasteride syndrome: a surmountable challenge for clinicians". <i>Fertility and Sterility</i>. <b>113</b> (1): 21–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.fertnstert.2019.11.030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.fertnstert.2019.11.030'" tppabs="https://doi.org/10.1016%2Fj.fertnstert.2019.11.030" class="external text external">10.1016/j.fertnstert.2019.11.030</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/32033719  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/32033719'" tppabs="https://pubmed.ncbi.nlm.nih.gov/32033719" class="external text external">32033719</a>.</cite></span></li><li id="cite_note-Fis2006-11"> <span id="mw-reference-text-cite_note-Fis2006-11" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA483'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA483" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>483. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-SataloffSclafani2015-12"> <span id="mw-reference-text-cite_note-SataloffSclafani2015-12" class="mw-reference-text"><cite id="CITEREFSataloffSclafani2015" class="citation book cs1">Sataloff RT, Sclafani AP (30 November 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400'" tppabs="https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400" class="external text external"><i>Sataloff's Comprehensive Textbook of Otolaryngology: Head &amp; Neck Surgery: Facial Plastic and Reconstructive Surgery</i></a>. JP Medical Ltd. pp.<span>&nbsp;</span>400–. ISBN<span>&nbsp;</span><bdi>978-93-5152-459-5</bdi>.</cite></span></li><li id="cite_note-BNF76-13"> <span id="mw-reference-text-cite_note-BNF76-13" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. p.<span>&nbsp;</span>769. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-NADAC2019-14"> <span id="mw-reference-text-cite_note-NADAC2019-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6" class="external text external">"NADAC as of 2019-02-27"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Finasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Finasteride'" tppabs="https://clincalc.com/DrugStats/Drugs/Finasteride" class="external text external">"Finasteride - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-ProscarLabel-17"> <span id="mw-reference-text-cite_note-ProscarLabel-17" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf" class="external text external">Proscar label</a></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text">Kanti V1, Messenger A2, Dobos G1, Reygagne P3, Finner A4, Blumeyer A5, Trakatelli M6, Tosti A7,8, Del Marmol V9, Piraccini BM10, Nast A11, Blume-Peytavi U1. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):11-22. doi: 10.1111/jdv.14624. Epub 2017 Nov 27.</span></li><li id="cite_note-PropeciaLabel-19"> <span id="mw-reference-text-cite_note-PropeciaLabel-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf" class="external text external">"Propecia label"</a> <span class="cs1-format">(PDF)</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFAdilGodwin2017" class="citation journal cs1">Adil A, Godwin M (July 2017). "The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis". <i>Journal of the American Academy of Dermatology</i>. <b>77</b> (1): 136–141.e5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2017.02.054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2017.02.054'" tppabs="https://doi.org/10.1016%2Fj.jaad.2017.02.054" class="external text external">10.1016/j.jaad.2017.02.054</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28396101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28396101'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28396101" class="external text external">28396101</a>.</cite></span></li><li id="cite_note-Habif2015-21"> <span id="mw-reference-text-cite_note-Habif2015-21" class="mw-reference-text"><cite id="CITEREFHabif2015" class="citation book cs1">Habif TP (23 April 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=N_D5CQAAQBAJ&pg=PA934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=N_D5CQAAQBAJ&pg=PA934'" tppabs="https://books.google.com/books?id=N_D5CQAAQBAJ&pg=PA934" class="external text external"><i>Clinical Dermatology</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>934–. ISBN<span>&nbsp;</span><bdi>978-0-323-26607-9</bdi>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFYimNoleTosti2014" class="citation journal cs1">Yim E, Nole KL, Tosti A (December 2014). "5α-Reductase inhibitors in androgenetic alopecia". <i>Current Opinion in Endocrinology, Diabetes and Obesity</i>. <b>21</b> (6): 493–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FMED.0000000000000112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FMED.0000000000000112'" tppabs="https://doi.org/10.1097%2FMED.0000000000000112" class="external text external">10.1097/MED.0000000000000112</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25268732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25268732'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25268732" class="external text external">25268732</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFGuptaCharrette2014" class="citation journal cs1">Gupta AK, Charrette A (April 2014). "The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride". <i>The Journal of Dermatological Treatment</i>. <b>25</b> (2): 156–61. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F09546634.2013.813011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F09546634.2013.813011'" tppabs="https://doi.org/10.3109%2F09546634.2013.813011" class="external text external">10.3109/09546634.2013.813011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23768246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23768246'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23768246" class="external text external">23768246</a>.</cite></span></li><li id="cite_note-FPArev-24"> <span id="mw-reference-text-cite_note-FPArev-24" class="mw-reference-text"><cite id="CITEREFLevyEmer2013" class="citation journal cs1">Levy LL, Emer JJ (August 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411" class="external text external">"Female pattern alopecia: current perspectives"</a>. <i>International Journal of Women's Health</i>. <b>5</b>: 541–56. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FIJWH.S49337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FIJWH.S49337'" tppabs="https://doi.org/10.2147%2FIJWH.S49337" class="external text external">10.2147/IJWH.S49337</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769411" class="external text external">3769411</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24039457  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24039457'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24039457" class="external text external">24039457</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cancer.gov/types/prostate/research/finasteride-reduces-low-grade  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cancer.gov/types/prostate/research/finasteride-reduces-low-grade'" tppabs="https://www.cancer.gov/types/prostate/research/finasteride-reduces-low-grade" class="external text external">"Finasteride for Prostate Cancer Prevention"</a>. <i>National Cancer Institute</i>. 28 August 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">8 February</span> 2020</span>.</cite></span></li><li id="cite_note-pmid20977593-26"> <span id="mw-reference-text-cite_note-pmid20977593-26" class="mw-reference-text"><cite id="CITEREFWiltMacdonaldHagertySchellhammer2010" class="citation journal cs1">Wilt TJ, Macdonald R, Hagerty K, Schellhammer P, Tacklind J, Somerfield MR, Kramer BS (2010). "5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review". <i>BJU Int</i>. <b>106</b> (10): 1444–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410X.2010.09714.x" class="external text external">10.1111/j.1464-410X.2010.09714.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20977593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20977593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20977593" class="external text external">20977593</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFUngerHershmanTillTangen2018" class="citation journal cs1">Unger JM, Hershman DL, Till C, Tangen CM, Barlow WE, Ramsey SD, Goodman PJ, Thompson IM (March 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685" class="external text external">"Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial"</a>. <i>Journal of the National Cancer Institute</i>. <b>110</b> (11): 1208–1215. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjnci%2Fdjy035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjnci%2Fdjy035'" tppabs="https://doi.org/10.1093%2Fjnci%2Fdjy035" class="external text external">10.1093/jnci/djy035</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235685" class="external text external">6235685</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29534197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29534197'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29534197" class="external text external">29534197</a>.</cite></span></li><li id="cite_note-Hirshburg2016-28"> <span id="mw-reference-text-cite_note-Hirshburg2016-28" class="mw-reference-text"><cite id="CITEREFHirshburgKelseyTherrienGavino2016" class="citation journal cs1">Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004" class="external text external">"Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review"</a>. <i>J Clin Aesthet Dermatol</i>. <b>9</b> (7): 56–62. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004" class="external text external">5023004</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27672412  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27672412'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27672412" class="external text external">27672412</a>.</cite></span></li><li id="cite_note-Trüeb2017-29"> <span id="mw-reference-text-cite_note-Trüeb2017-29" class="mw-reference-text"><cite id="CITEREFTrüeb2017" class="citation journal cs1">Trüeb, Ralph M. (2017). "Discriminating in favour of or against men with increased risk of finasteride-related side effects?". <i>Experimental Dermatology</i>. <b>26</b> (6): 527–528. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fexd.13155  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fexd.13155'" tppabs="https://doi.org/10.1111%2Fexd.13155" class="external text external">10.1111/exd.13155</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0906-6705  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0906-6705'" tppabs="https://www.worldcat.org/issn/0906-6705" class="external text external">0906-6705</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27489125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27489125'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27489125" class="external text external">27489125</a>. <q>[...] caution is recommended while prescribing oral finasteride to male-to-female transsexuals, as the drug has been associated with inducing depression, anxiety and suicidal ideation, symptoms that are particularly common in patients with gender dysphoria, who are already at a high risk.[9]</q></cite></span></li><li id="cite_note-FDA1997-30"> <span id="mw-reference-text-cite_note-FDA1997-30" class="mw-reference-text"><cite id="CITEREFFDA" class="citation web cs1">FDA. <a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20788_PROPECIA%20TABLETS,%201MG_MEDR_P4.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20788_PROPECIA%20TABLETS,%201MG_MEDR_P4.PDF'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20788_PROPECIA%20TABLETS,%201MG_MEDR_P4.PDF" class="external text external">"Summary of Key Safety Findings"</a> <span class="cs1-format">(PDF)</span>. p.<span>&nbsp;</span>98.</cite></span></li><li id="cite_note-:0-31"> <span id="mw-reference-text-cite_note-:0-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf" class="external text external">"PROPECIA Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. US Food &amp; Drug Administration / Merck &amp; Co., Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">30 January</span> 2020</span>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf" class="external text external">"PROSCAR Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. US Food &amp; Drug Administration / Merck &amp; Co., Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">30 January</span> 2020</span>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/media/70929/download  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/media/70929/download'" tppabs="https://www.fda.gov/media/70929/download" class="external text external">"Deferral of Blood and Plasma donors – Medications"</a>. FDA. 28 July 1993<span class="reference-accessdate">. Retrieved <span class="nowrap">30 January</span> 2020</span>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text">FDA. Posted 9 June 2011. <a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm" class="external text external">5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer</a></span></li><li id="cite_note-pmid20357287-35"> <span id="mw-reference-text-cite_note-pmid20357287-35" class="mw-reference-text"><cite id="CITEREFWalsh2010" class="citation journal cs1">Walsh PC (April 2010). "Chemoprevention of prostate cancer". <i>The New England Journal of Medicine</i>. <b>362</b> (13): 1237–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMe1001045  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMe1001045'" tppabs="https://doi.org/10.1056%2FNEJMe1001045" class="external text external">10.1056/NEJMe1001045</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20357287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20357287'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20357287" class="external text external">20357287</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text">Medicines and Healthcare products Regulatory Agency Drug Safety Update. December 2009 <a href="javascript:if(confirm('http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087725'" tppabs="http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087725" class="external text external">Finasteride: potential risk of male breast cancer</a></span></li><li id="cite_note-pmid29697934-37"> <span id="mw-reference-text-cite_note-pmid29697934-37" class="mw-reference-text"><cite id="CITEREFWangZhaoLuoLi2018" class="citation journal cs1">Wang J, Zhao S, Luo L, Li E, Li X, Zhao Z (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523" class="external text external">"5-alpha Reductase Inhibitors and risk of male breast cancer: a systematic review and meta-analysis"</a>. <i>Int Braz J Urol</i>. <b>44</b> (5): 865–873. doi:<a href="javascript:if(confirm('https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531'" tppabs="https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531" class="external text external">10.1590/S1677-5538.IBJU.2017.0531</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523" class="external text external">6237523</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29697934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29697934'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29697934" class="external text external">29697934</a>.</cite></span></li><li id="cite_note-Narula2014-38"> <span id="mw-reference-text-cite_note-Narula2014-38" class="mw-reference-text"><cite id="CITEREFNarulaCarlson2014" class="citation journal cs1">Narula HS, Carlson HE (August 2014). <a href="javascript:if(confirm('https://touroscholar.touro.edu/tuncom_pubs/54  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://touroscholar.touro.edu/tuncom_pubs/54'" tppabs="https://touroscholar.touro.edu/tuncom_pubs/54" class="external text external">"Gynaecomastia-pathophysiology, diagnosis and treatment"</a>. <i>Nat Rev Endocrinol</i>. <b>10</b> (11): 684–698. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrendo.2014.139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrendo.2014.139'" tppabs="https://doi.org/10.1038%2Fnrendo.2014.139" class="external text external">10.1038/nrendo.2014.139</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25112235  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25112235'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25112235" class="external text external">25112235</a>.</cite></span></li><li id="cite_note-Drugs-39"> <span id="mw-reference-text-cite_note-Drugs-39" class="mw-reference-text"><cite id="CITEREFDeepinderBraunstein2012" class="citation journal cs1">Deepinder F, Braunstein GD (2012). "Drug-induced gynecomastia: an evidence-based review". <i>Expert Opinion on Drug Safety</i>. <b>11</b> (5): 779–795. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2012.712109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2012.712109'" tppabs="https://doi.org/10.1517%2F14740338.2012.712109" class="external text external">10.1517/14740338.2012.712109</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22862307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22862307'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22862307" class="external text external">22862307</a>.</cite></span></li><li id="cite_note-Bolignano2014-40"> <span id="mw-reference-text-cite_note-Bolignano2014-40" class="mw-reference-text"><cite id="CITEREFBolignanoPalmerNavaneethanStrippoli2014" class="citation journal cs1">Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF (April 2014). "Aldosterone antagonists for preventing the progression of chronic kidney disease". <i>Cochrane Database of Systematic Reviews</i>. <b>4</b> (4): CD007004. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD007004.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD007004.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD007004.pub3" class="external text external">10.1002/14651858.CD007004.pub3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24782282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24782282'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24782282" class="external text external">24782282</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFAimanHaseeenRahman2009" class="citation journal cs1">Aiman U, Haseeen MA, Rahman SZ (December 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505" class="external text external">"Gynecomastia: An ADR due to drug interaction"</a>. <i>Indian Journal of Pharmacology</i>. <b>41</b> (6): 286–7. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2F0253-7613.59929  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2F0253-7613.59929'" tppabs="https://doi.org/10.4103%2F0253-7613.59929" class="external text external">10.4103/0253-7613.59929</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846505" class="external text external">2846505</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20407562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20407562'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20407562" class="external text external">20407562</a>.</cite></span></li><li id="cite_note-pmid27784557-42"> <span id="mw-reference-text-cite_note-pmid27784557-42" class="mw-reference-text"><cite id="CITEREFTrostSaitzHellstrom2013" class="citation journal cs1">Trost L, Saitz TR, Hellstrom WJ (2013). "Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review". <i>Sex Med Rev</i>. <b>1</b> (1): 24–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fsmrj.3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fsmrj.3'" tppabs="https://doi.org/10.1002%2Fsmrj.3" class="external text external">10.1002/smrj.3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27784557  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27784557'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27784557" class="external text external">27784557</a>.</cite></span></li><li id="cite_note-pmid28456011-43"> <span id="mw-reference-text-cite_note-pmid28456011-43" class="mw-reference-text"><cite id="CITEREFLocciPinna2017" class="citation journal cs1">Locci A, Pinna G (2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768" class="external text external">"Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment"</a>. <i>Br. J. Pharmacol</i>. <b>174</b> (19): 3226–3241. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fbph.13843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fbph.13843'" tppabs="https://doi.org/10.1111%2Fbph.13843" class="external text external">10.1111/bph.13843</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768" class="external text external">5595768</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28456011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28456011'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28456011" class="external text external">28456011</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFFDA2012" class="citation web cs1">FDA (11 April 2012). <a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm299754.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm299754.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm299754.htm" class="external text external">"Questions and Answers: Finasteride Label Changes"</a>. US FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">26 October</span> 2014</span>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://peerj.com/articles/3020.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://peerj.com/articles/3020.pdf'" tppabs="https://peerj.com/articles/3020.pdf" class="external text external">"Persistent erectile dysfunction in men exposed to the 5a-reductase inhibitors, finasteride, or dutasteride"</a> <span class="cs1-format">(PDF)</span>. 9 March 2017.</cite></span></li><li id="cite_note-Mella_JM_2010-46"> <span id="mw-reference-text-cite_note-Mella_JM_2010-46" class="mw-reference-text"><cite id="CITEREFMellaPerretManzottiCatalano2010" class="citation journal cs1">Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G (October 2010). "Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review". <i>Archives of Dermatology</i>. <b>146</b> (10): 1141–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchdermatol.2010.256  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchdermatol.2010.256'" tppabs="https://doi.org/10.1001%2Farchdermatol.2010.256" class="external text external">10.1001/archdermatol.2010.256</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20956649  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20956649'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20956649" class="external text external">20956649</a>.</cite></span></li><li id="cite_note-Gur2013-47"> <span id="mw-reference-text-cite_note-Gur2013-47" class="mw-reference-text"><cite id="CITEREFGurKadowitzHellstrom2013" class="citation journal cs1">Gur S, Kadowitz PJ, Hellstrom WJ (January 2013). "Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation". <i>Expert Opinion on Drug Safety</i>. <b>12</b> (1): 81–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2013.742885  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2013.742885'" tppabs="https://doi.org/10.1517%2F14740338.2013.742885" class="external text external">10.1517/14740338.2013.742885</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23173718  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23173718'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23173718" class="external text external">23173718</a>.</cite></span></li><li id="cite_note-Reut2019a-48"> <span id="mw-reference-text-cite_note-Reut2019a-48" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.reuters.com/investigates/special-report/usa-courts-secrecy-propecia/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/investigates/special-report/usa-courts-secrecy-propecia/'" tppabs="https://www.reuters.com/investigates/special-report/usa-courts-secrecy-propecia/" class="external text external">"U.S. court let Merck hide secrets about popular drug's risks"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">17 February</span> 2020</span>.</cite></span></li><li id="cite_note-Reut2019pdf-49"> <span id="mw-reference-text-cite_note-Reut2019pdf-49" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.reuters.com/investigates/special-report/assets/usa-courts-secrecy-propecia/howes-deposition.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/investigates/special-report/assets/usa-courts-secrecy-propecia/howes-deposition.pdf'" tppabs="https://www.reuters.com/investigates/special-report/assets/usa-courts-secrecy-propecia/howes-deposition.pdf" class="external text external">"In re: Propecia (Finasteride) Products"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">17 February</span> 2020</span>.</cite></span></li><li id="cite_note-pmid16719800-50"> <span id="mw-reference-text-cite_note-pmid16719800-50" class="mw-reference-text"><cite id="CITEREFFrye2006" class="citation journal cs1">Frye SV (2006). "Discovery and clinical development of dutasteride, a potent dual 5alpha-reductase inhibitor". <i>Curr Top Med Chem</i>. <b>6</b> (5): 405–21. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F156802606776743101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F156802606776743101'" tppabs="https://doi.org/10.2174%2F156802606776743101" class="external text external">10.2174/156802606776743101</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16719800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16719800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16719800" class="external text external">16719800</a>.</cite></span></li><li id="cite_note-pmid7689728-51"> <span id="mw-reference-text-cite_note-pmid7689728-51" class="mw-reference-text"><cite id="CITEREFSudduthKoronkowski1993" class="citation journal cs1">Sudduth SL, Koronkowski MJ (1993). "Finasteride: the first 5α-reductase inhibitor". <i>Pharmacotherapy</i>. <b>13</b> (4): 309–25, discussion 325–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1875-9114.1993.tb02739.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1875-9114.1993.tb02739.x'" tppabs="https://doi.org/10.1002%2Fj.1875-9114.1993.tb02739.x" class="external text external">10.1002/j.1875-9114.1993.tb02739.x</a> (inactive 7 May 2020). PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7689728  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7689728'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7689728" class="external text external">7689728</a>.</cite></span></li><li id="cite_note-Yamana2010-52"> <span id="mw-reference-text-cite_note-Yamana2010-52" class="mw-reference-text"><cite id="CITEREFYamanaLabrieLuu-The2010" class="citation journal cs1">Yamana K, Labrie F, Luu-The V (August 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". <i>Hormone Molecular Biology and Clinical Investigation</i>. <b>2</b> (3): 293–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fhmbci.2010.035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fhmbci.2010.035'" tppabs="https://doi.org/10.1515%2Fhmbci.2010.035" class="external text external">10.1515/hmbci.2010.035</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25961201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25961201'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25961201" class="external text external">25961201</a>.</cite></span></li><li id="cite_note-pmid19879888-53"> <span id="mw-reference-text-cite_note-pmid19879888-53" class="mw-reference-text"><cite id="CITEREFAggarwalTharejaVermaBhardwaj2010" class="citation journal cs1">Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M (February 2010). "An overview on 5alpha-reductase inhibitors". <i>Steroids</i>. <b>75</b> (2): 109–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.steroids.2009.10.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.steroids.2009.10.005'" tppabs="https://doi.org/10.1016%2Fj.steroids.2009.10.005" class="external text external">10.1016/j.steroids.2009.10.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19879888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19879888'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19879888" class="external text external">19879888</a>.</cite></span></li><li id="cite_note-Azz-54"> <span id="mw-reference-text-cite_note-Azz-54" class="mw-reference-text"><cite id="CITEREFAzzouniGodoyLiMohler2012" class="citation journal cs1">Azzouni F, Godoy A, Li Y, Mohler J (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436" class="external text external">"The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases"</a>. <i>Adv Urol</i>. <b>2012</b>: 1–18. doi:<a href="javascript:if(confirm('https://doi.org/10.1155%2F2012%2F530121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F2012%2F530121'" tppabs="https://doi.org/10.1155%2F2012%2F530121" class="external text external">10.1155/2012/530121</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436" class="external text external">3253436</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22235201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22235201'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22235201" class="external text external">22235201</a>.</cite></span></li><li id="cite_note-Preedy2012-55"> <span id="mw-reference-text-cite_note-Preedy2012-55" class="mw-reference-text"><cite id="CITEREFVictor_R._Preedy2012" class="citation book cs1">Victor R. Preedy (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=7N3nEX6eL_MC&pg=PA89  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7N3nEX6eL_MC&pg=PA89'" tppabs="https://books.google.com/books?id=7N3nEX6eL_MC&pg=PA89" class="external text external"><i>Handbook of Hair in Health and Disease</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>89–. ISBN<span>&nbsp;</span><bdi>978-90-8686-728-8</bdi>.</cite></span></li><li id="cite_note-Wu2012-56"> <span id="mw-reference-text-cite_note-Wu2012-56" class="mw-reference-text"><cite id="CITEREFJashin_J._Wu2012" class="citation book cs1">Jashin J. Wu (18 October 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=Tqpsm5WKKlcC&pg=PA361  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Tqpsm5WKKlcC&pg=PA361'" tppabs="https://books.google.com/books?id=Tqpsm5WKKlcC&pg=PA361" class="external text external"><i>Comprehensive Dermatologic Drug Therapy E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>361–. ISBN<span>&nbsp;</span><bdi>978-1-4557-3801-4</bdi>.</cite></span></li><li id="cite_note-ClapauchWeiss2017-57"> <span id="mw-reference-text-cite_note-ClapauchWeiss2017-57" class="mw-reference-text"><cite id="CITEREFClapauchWeissRech2017" class="citation book cs1">Clapauch, Ruth; Weiss, Rita Vasconcellos; Rech, Ciciliana Maila Zilio (2017). "Testosterone and Women". <i>Testosterone</i>. pp.<span>&nbsp;</span>319–351. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-319-46086-4_17  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-319-46086-4_17'" tppabs="https://doi.org/10.1007%2F978-3-319-46086-4_17" class="external text external">10.1007/978-3-319-46086-4_17</a>. ISBN<span>&nbsp;</span><bdi>978-3-319-46084-0</bdi>. <q>Finasteride is not actually an antiandrogen but a 5α-reductase inhibitor.</q></cite></span></li><li id="cite_note-pmid10765065-58"> <span id="mw-reference-text-cite_note-pmid10765065-58" class="mw-reference-text"><cite id="CITEREFBartschRittmasterKlocker2000" class="citation journal cs1">Bartsch G, Rittmaster RS, Klocker H (April 2000). "Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia". <i>European Urology</i>. <b>37</b> (4): 367–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000020181  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000020181'" tppabs="https://doi.org/10.1159%2F000020181" class="external text external">10.1159/000020181</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10765065  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10765065'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10765065" class="external text external">10765065</a>.</cite></span></li><li id="cite_note-pmid29379733-59"> <span id="mw-reference-text-cite_note-pmid29379733-59" class="mw-reference-text"><cite id="CITEREFKimBrockmanAndriole2018" class="citation journal cs1">Kim EH, Brockman JA, Andriole GL (January 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290" class="external text external">"The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia"</a>. <i>Asian Journal of Urology</i>. <b>5</b> (1): 28–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ajur.2017.11.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ajur.2017.11.005'" tppabs="https://doi.org/10.1016%2Fj.ajur.2017.11.005" class="external text external">10.1016/j.ajur.2017.11.005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780290" class="external text external">5780290</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29379733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29379733'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29379733" class="external text external">29379733</a>.</cite></span></li><li id="cite_note-pmid7505051-60"> <span id="mw-reference-text-cite_note-pmid7505051-60" class="mw-reference-text"><cite id="CITEREFRittmaster1994" class="citation journal cs1">Rittmaster RS (January 1994). "Finasteride". <i>N. Engl. J. Med</i>. <b>330</b> (2): 120–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM199401133300208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM199401133300208'" tppabs="https://doi.org/10.1056%2FNEJM199401133300208" class="external text external">10.1056/NEJM199401133300208</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7505051  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7505051'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7505051" class="external text external">7505051</a>.</cite></span></li><li id="cite_note-pmid15102575-61"> <span id="mw-reference-text-cite_note-pmid15102575-61" class="mw-reference-text"><cite id="CITEREFLibeccoBergfeld2004" class="citation journal cs1">Libecco JF, Bergfeld WF (April 2004). "Finasteride in the treatment of alopecia". <i>Expert Opin Pharmacother</i>. <b>5</b> (4): 933–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.5.4.933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.5.4.933'" tppabs="https://doi.org/10.1517%2F14656566.5.4.933" class="external text external">10.1517/14656566.5.4.933</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15102575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15102575'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15102575" class="external text external">15102575</a>.</cite></span></li><li id="cite_note-pmid12894990-62"> <span id="mw-reference-text-cite_note-pmid12894990-62" class="mw-reference-text"><cite id="CITEREFShapiroKaufman2003" class="citation journal cs1">Shapiro J, Kaufman KD (June 2003). "Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss)". <i>J. Investig. Dermatol. Symp. Proc</i>. <b>8</b> (1): 20–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1523-1747.2003.12167.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1523-1747.2003.12167.x'" tppabs="https://doi.org/10.1046%2Fj.1523-1747.2003.12167.x" class="external text external">10.1046/j.1523-1747.2003.12167.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12894990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12894990'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12894990" class="external text external">12894990</a>.</cite></span></li><li id="cite_note-pmid19515843-63"> <span id="mw-reference-text-cite_note-pmid19515843-63" class="mw-reference-text"><cite id="CITEREFDruryDi_CostanzoPenningChristianson2009" class="citation journal cs1">Drury JE, Di Costanzo L, Penning TM, Christianson DW (July 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403" class="external text external">"Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex"</a>. <i>The Journal of Biological Chemistry</i>. <b>284</b> (30): 19786–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1074%2Fjbc.C109.016931  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1074%2Fjbc.C109.016931'" tppabs="https://doi.org/10.1074%2Fjbc.C109.016931" class="external text external">10.1074/jbc.C109.016931</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740403" class="external text external">2740403</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19515843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19515843'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19515843" class="external text external">19515843</a>.</cite></span></li><li id="cite_note-BostwickCheng2014-64"> <span id="mw-reference-text-cite_note-BostwickCheng2014-64" class="mw-reference-text"><cite id="CITEREFBostwickCheng2014" class="citation book cs1">Bostwick DG, Cheng L (24 January 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA402'" tppabs="https://books.google.com/books?id=wrHQAgAAQBAJ&pg=PA402" class="external text external"><i>Urologic Surgical Pathology E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>402–. ISBN<span>&nbsp;</span><bdi>978-0-323-08619-6</bdi>.</cite></span></li><li id="cite_note-pmid16476520-65"> <span id="mw-reference-text-cite_note-pmid16476520-65" class="mw-reference-text"><cite id="CITEREFRobaireHenderson2006" class="citation journal cs1">Robaire B, Henderson NA (May 2006). "Actions of 5alpha-reductase inhibitors on the epididymis". <i>Molecular and Cellular Endocrinology</i>. <b>250</b> (1–2): 190–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mce.2005.12.044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mce.2005.12.044'" tppabs="https://doi.org/10.1016%2Fj.mce.2005.12.044" class="external text external">10.1016/j.mce.2005.12.044</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16476520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16476520'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16476520" class="external text external">16476520</a>.</cite></span></li><li id="cite_note-pmid16834758-66"> <span id="mw-reference-text-cite_note-pmid16834758-66" class="mw-reference-text"><cite id="CITEREFFinnBeadles-BohlingBeckleyFord2006" class="citation journal cs1">Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM (2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762" class="external text external">"A new look at the 5alpha-reductase inhibitor finasteride"</a>. <i>CNS Drug Reviews</i>. <b>12</b> (1): 53–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1527-3458.2006.00053.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1527-3458.2006.00053.x'" tppabs="https://doi.org/10.1111%2Fj.1527-3458.2006.00053.x" class="external text external">10.1111/j.1527-3458.2006.00053.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762" class="external text external">6741762</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16834758  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16834758'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16834758" class="external text external">16834758</a>.</cite></span></li><li id="cite_note-pmid21122055-67"> <span id="mw-reference-text-cite_note-pmid21122055-67" class="mw-reference-text"><cite id="CITEREFRömerGass2010" class="citation journal cs1">Römer B, Gass P (December 2010). <a href="javascript:if(confirm('https://zenodo.org/record/896024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/896024'" tppabs="https://zenodo.org/record/896024" class="external text external">"Finasteride-induced depression: new insights into possible pathomechanisms"</a>. <i>Journal of Cosmetic Dermatology</i>. <b>9</b> (4): 331–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1473-2165.2010.00533.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1473-2165.2010.00533.x'" tppabs="https://doi.org/10.1111%2Fj.1473-2165.2010.00533.x" class="external text external">10.1111/j.1473-2165.2010.00533.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21122055  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21122055'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21122055" class="external text external">21122055</a>.</cite></span></li><li id="cite_note-pmid22164129-68"> <span id="mw-reference-text-cite_note-pmid22164129-68" class="mw-reference-text"><cite id="CITEREFGunnBrownLambertBelelli2011" class="citation journal cs1">Gunn BG, Brown AR, Lambert JJ, Belelli D (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140" class="external text external">"Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress"</a>. <i>Frontiers in Neuroscience</i>. <b>5</b>: 131. doi:<a href="javascript:if(confirm('https://doi.org/10.3389%2Ffnins.2011.00131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3389%2Ffnins.2011.00131'" tppabs="https://doi.org/10.3389%2Ffnins.2011.00131" class="external text external">10.3389/fnins.2011.00131</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230140" class="external text external">3230140</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22164129  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22164129'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22164129" class="external text external">22164129</a>.</cite></span></li><li id="cite_note-pmid8117686-69"> <span id="mw-reference-text-cite_note-pmid8117686-69" class="mw-reference-text"><cite id="CITEREFTianStuartMossDomanico1994" class="citation journal cs1">Tian G, Stuart JD, Moss ML, Domanico PL, Bramson HN, Patel IR, Kadwell SH, Overton LK, Kost TA, Mook RA (1994). "17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1". <i>Biochemistry</i>. <b>33</b> (8): 2291–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fbi00174a041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fbi00174a041'" tppabs="https://doi.org/10.1021%2Fbi00174a041" class="external text external">10.1021/bi00174a041</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8117686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8117686'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8117686" class="external text external">8117686</a>.</cite></span></li><li id="cite_note-micro-70"> <span id="mw-reference-text-cite_note-micro-70" class="mw-reference-text"><cite id="CITEREFAzeemKhanAqilAhmad2009" class="citation journal cs1">Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, Talegaonkar S (May 2009). "Microemulsions as a surrogate carrier for dermal drug delivery". <i>Drug Development and Industrial Pharmacy</i>. <b>35</b> (5): 525–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F03639040802448646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F03639040802448646'" tppabs="https://doi.org/10.1080%2F03639040802448646" class="external text external">10.1080/03639040802448646</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19016057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19016057'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19016057" class="external text external">19016057</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite id="CITEREFHamilton1942" class="citation journal cs1">Hamilton, J (1942). "Male hormone stimulation is prerequisite and an incitant in common baldness". <i>American Journal of Anatomy</i>. <b>71</b> (3): 451–480. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Faja.1000710306  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Faja.1000710306'" tppabs="https://doi.org/10.1002%2Faja.1000710306" class="external text external">10.1002/aja.1000710306</a>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.bbc.co.uk/news/magazine-34290981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bbc.co.uk/news/magazine-34290981'" tppabs="https://www.bbc.co.uk/news/magazine-34290981" class="external text external">"The extraordinary case of the Guevedoces"</a>. <i>BBC News</i>. 20 September 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">3 September</span> 2018</span>.</cite></span></li><li id="cite_note-pmid4432067-73"> <span id="mw-reference-text-cite_note-pmid4432067-73" class="mw-reference-text"><cite id="CITEREFImperato-McGinleyGuerreroGautierPeterson1974" class="citation journal cs1">Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (December 1974). "Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism". <i>Science</i>. <b>186</b> (4170): 1213–5. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1974Sci...186.1213I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1974Sci...186.1213I'" tppabs="https://ui.adsabs.harvard.edu/abs/1974Sci...186.1213I" class="external text external">1974Sci...186.1213I</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1126%2Fscience.186.4170.1213  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1126%2Fscience.186.4170.1213'" tppabs="https://doi.org/10.1126%2Fscience.186.4170.1213" class="external text external">10.1126/science.186.4170.1213</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4432067  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4432067'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4432067" class="external text external">4432067</a>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite id="CITEREFIsfortEmerickPaz2016" class="citation journal cs1">Isfort AH, Emerick JE, Paz RA (11 November 2016). <a href="javascript:if(confirm('http://emedicine.medscape.com/article/924291-overview  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emedicine.medscape.com/article/924291-overview#showall'" tppabs="http://emedicine.medscape.com/article/924291-overview#showall" class="external text external">"5-Alpha-Reductase Deficiency"</a>. <i>WebMD</i>. News &amp; Perspective Drugs &amp; Diseases CME &amp; Education Academy Consult, Drugs &amp; Diseases &gt; Pediatrics: General Medicine.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite id="CITEREFFreudenheim1992" class="citation news cs1">Freudenheim M (16 February 1992). <a href="javascript:if(confirm('https://www.nytimes.com/1992/02/16/business/keeping-the-pipeline-filled-at-merck.html?src=pm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1992/02/16/business/keeping-the-pipeline-filled-at-merck.html?src=pm'" tppabs="https://www.nytimes.com/1992/02/16/business/keeping-the-pipeline-filled-at-merck.html?src=pm" class="external text external">"Keeping the Pipeline Filled at Merck"</a>. <i>The New York Times</i>.</cite></span></li><li id="cite_note-Cordes2014-76"> <span id="mw-reference-text-cite_note-Cordes2014-76" class="mw-reference-text"><cite id="CITEREFCordes2014" class="citation book cs1">Cordes E (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=_G9VAgAAQBAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=_G9VAgAAQBAJ'" tppabs="https://books.google.com/books?id=_G9VAgAAQBAJ" class="external text external"><i>Hallelujah Moments: Tales of Drug Discovery</i></a>. Oxford University Press. ISBN<span>&nbsp;</span><bdi>9780199337149</bdi>.</cite></span></li><li id="cite_note-IPOInventor-77"> <span id="mw-reference-text-cite_note-IPOInventor-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ipoef.org/past-ioy-winners  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ipoef.org/past-ioy-winners'" tppabs="https://www.ipoef.org/past-ioy-winners" class="external text external">"Past Inventor of the Year Award Winners"</a>. <i>ipoef.org</i>. Intellectual Property Owners Education Foundation<span class="reference-accessdate">. Retrieved <span class="nowrap">21 June</span> 2020</span>.</cite></span></li><li id="cite_note-BurgerAbraham2003-78"> <span id="mw-reference-text-cite_note-BurgerAbraham2003-78" class="mw-reference-text"><cite id="CITEREFBurgerAbraham2003" class="citation book cs1">Burger A, Abraham DJ (20 February 2003). <a href="javascript:if(confirm('https://books.google.com/books?id=25ZUAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=25ZUAAAAMAAJ'" tppabs="https://books.google.com/books?id=25ZUAAAAMAAJ" class="external text external"><i>Burger's Medicinal Chemistry and Drug Discovery, Autocoids, Diagnostics, and Drugs from New Biology</i></a>. Wiley. p.<span>&nbsp;</span>439. ISBN<span>&nbsp;</span><bdi>978-0-471-37030-7</bdi>.</cite></span></li><li id="cite_note-Doherty2003-79"> <span id="mw-reference-text-cite_note-Doherty2003-79" class="mw-reference-text"><cite id="CITEREFDoherty2003" class="citation book cs1">Doherty AM (2003). <a href="javascript:if(confirm('https://books.google.com/books?id=ECfQ6D5JLusC&pg=PA353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ECfQ6D5JLusC&pg=PA353'" tppabs="https://books.google.com/books?id=ECfQ6D5JLusC&pg=PA353" class="external text external"><i>Annual Reports in Medicinal Chemistry</i></a>. Academic Press. pp.<span>&nbsp;</span>353–. ISBN<span>&nbsp;</span><bdi>978-0-12-040538-1</bdi>.</cite></span></li><li id="cite_note-pmid9420861-80"> <span id="mw-reference-text-cite_note-pmid9420861-80" class="mw-reference-text"><cite id="CITEREFDiamanti-KandarakisTolisDuleba1995" class="citation journal cs1">Diamanti-Kandarakis E, Tolis G, Duleba AJ (1995). "Androgens and therapeutic aspects of antiandrogens in women". <i>J. Soc. Gynecol. Investig</i>. <b>2</b> (4): 577–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F107155769500200401  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F107155769500200401'" tppabs="https://doi.org/10.1177%2F107155769500200401" class="external text external">10.1177/107155769500200401</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9420861  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9420861'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9420861" class="external text external">9420861</a>.</cite></span></li><li id="cite_note-IndexNominum2000-81"> <span id="mw-reference-text-cite_note-IndexNominum2000-81" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PP1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PP1'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PP1" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. p.<span>&nbsp;</span>443. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-MortonHall2012-82"> <span id="mw-reference-text-cite_note-MortonHall2012-82" class="mw-reference-text"><cite id="CITEREFI.K._MortonJudith_M._Hall2012" class="citation book cs1">I.K. Morton; Judith M. Hall (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA121'" tppabs="https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA121" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>121–. ISBN<span>&nbsp;</span><bdi>978-94-011-4439-1</bdi>.</cite></span></li><li id="cite_note-BycroftPayne2013-83"> <span id="mw-reference-text-cite_note-BycroftPayne2013-83" class="mw-reference-text"><cite id="CITEREFBarrie_W._BycroftDavid_J._Payne2013" class="citation book cs1">Barrie W. Bycroft; David J. Payne (9 August 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=x0hZDwAAQBAJ&pg=PA816  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=x0hZDwAAQBAJ&pg=PA816'" tppabs="https://books.google.com/books?id=x0hZDwAAQBAJ&pg=PA816" class="external text external"><i>Dictionary of Antibiotics and Related Substances: with CD-ROM, Second Edition</i></a>. CRC Press. pp.<span>&nbsp;</span>816–. ISBN<span>&nbsp;</span><bdi>978-1-4822-8215-3</bdi>.</cite></span></li><li id="cite_note-Drugs.com-84"> <span id="mw-reference-text-cite_note-Drugs.com-84" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/finasteride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/finasteride.html'" tppabs="https://www.drugs.com/international/finasteride.html" class="external text external">"Finasteride"</a>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20080321140432/http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080321140432/http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19'" tppabs="https://web.archive.org/web/20080321140432/http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19" class="external text external">"Primary Patent Expirations for Selected High Revenue Drugs"</a>. <i>RxNews</i>. Prescription Solutions. Archived from <a href="javascript:if(confirm('http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19'" tppabs="http://www.rxsolutions.com/c/rxnews/rxnews_view.asp?Article=674&type=19" class="external text external">the original</a> on 21 March 2008.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite class="citation web cs1">FDA. <a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=020788&Product_No=001&table1=OB_Rx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=020788&Product_No=001&table1=OB_Rx'" tppabs="http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=020788&Product_No=001&table1=OB_Rx" class="external text external">"Patent Expiration for Propecia"</a>. <i>Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations</i>.</cite></span></li><li id="cite_note-Margo-87"> <span id="mw-reference-text-cite_note-Margo-87" class="mw-reference-text"><cite id="CITEREFMargo2012" class="citation web cs1">Margo J (26 September 2012). <a href="javascript:if(confirm('https://web.archive.org/web/20121114220945/http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20121114220945/http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ'" tppabs="https://web.archive.org/web/20121114220945/http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ" class="external text external">"Looking at care with a critical eye"</a>. <i>Australian Financial Review</i>. Archived from <a href="javascript:if(confirm('http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ'" tppabs="http://www.afr.com/p/lifestyle/mens_health/looking_at_care_with_critical_eye_ZRbAzUV4cRxZhspW7YRwBJ" class="external text external">the original</a> on 14 November 2012.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite id="CITEREFDaniel_Marchalik2017" class="citation news cs1">Daniel Marchalik (4 February 2017). <a href="javascript:if(confirm('https://www.miamiherald.com/news/nation-world/national/article130815949.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.miamiherald.com/news/nation-world/national/article130815949.html'" tppabs="https://www.miamiherald.com/news/nation-world/national/article130815949.html" class="external text external">"Watch for these potential side effects in drug Trump reportedly takes for hair loss"</a>. <i>Miami Herald</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 December</span> 2018</span>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFSandomir2006" class="citation news cs1">Sandomir R (19 January 2006). <a href="javascript:if(confirm('https://query.nytimes.com/gst/fullpage.html?sec=health&res=9F02E2DB153FF93AA25752C0A9609C8B63&n=Top%2fReference%2fTimes%20Topics%2fSubjects%2fO%2fOlympic%20Games  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://query.nytimes.com/gst/fullpage.html?sec=health&res=9F02E2DB153FF93AA25752C0A9609C8B63&n=Top%2fReference%2fTimes%20Topics%2fSubjects%2fO%2fOlympic%20Games'" tppabs="https://query.nytimes.com/gst/fullpage.html?sec=health&res=9F02E2DB153FF93AA25752C0A9609C8B63&n=Top%2fReference%2fTimes%20Topics%2fSubjects%2fO%2fOlympic%20Games" class="external text external">"Skin Deep; Fighting Baldness, and Now an Olympic Ban"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 May</span> 2010</span>.</cite></span></li><li id="cite_note-Australian-90"> <span id="mw-reference-text-cite_note-Australian-90" class="mw-reference-text"><cite id="CITEREFStaff2008" class="citation web cs1">Staff (28 October 2008). <a href="javascript:if(confirm('http://www.theaustralian.com.au/archive/news/wada-removes-finasteride-from-ban-list/story-e6frg7mo-1111117876628?nk=0afe1009eb17d32f8f4d47ff9e091a08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.theaustralian.com.au/archive/news/wada-removes-finasteride-from-ban-list/story-e6frg7mo-1111117876628?nk=0afe1009eb17d32f8f4d47ff9e091a08'" tppabs="http://www.theaustralian.com.au/archive/news/wada-removes-finasteride-from-ban-list/story-e6frg7mo-1111117876628?nk=0afe1009eb17d32f8f4d47ff9e091a08" class="external text external">"WADA removes Finasteride from ban list"</a>. <i>The Australian</i>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite class="citation web cs1">Staff (9 October 2008). <a href="javascript:if(confirm('http://www.smh.com.au/zoom/archive/d229652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.smh.com.au/zoom/archive/d229652'" tppabs="http://www.smh.com.au/zoom/archive/d229652" class="external text external">"WADA takes Romario's drug off banned list"</a>. <i>Sydney Morning Herald</i>.</cite></span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/downloads/BiologicsBloodVaccines/.../UCM062813.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/BiologicsBloodVaccines/.../UCM062813.pdf'" tppabs="https://www.fda.gov/downloads/BiologicsBloodVaccines/.../UCM062813.pdf" class="external text external">"Deferral of Blood and Plasma donors – Medications"</a> <span class="cs1-format">(PDF)</span>. FDA. 28 July 1993<span class="reference-accessdate">. Retrieved <span class="nowrap">4 February</span> 2017</span>.</cite></span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.transfusionguidelines.org/dsg/wb/guidelines/an027-anti-androgens  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.transfusionguidelines.org/dsg/wb/guidelines/an027-anti-androgens'" tppabs="https://www.transfusionguidelines.org/dsg/wb/guidelines/an027-anti-androgens" class="external text external">"Anti-Androgens - Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee"</a>. <i>www.transfusionguidelines.org</i>. 1 June 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">13 May</span> 2020</span>.</cite></span></li><li id="cite_note-94"> <span id="mw-reference-text-cite_note-94" class="mw-reference-text"><cite id="CITEREFSchechter2018" class="citation news cs1">Schechter, Anna R. (1 May 2018). <a href="javascript:if(confirm('https://www.nbcnews.com/politics/donald-trump/trump-doc-says-trump-bodyguard-lawyer-raided-his-office-took-n870351  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nbcnews.com/politics/donald-trump/trump-doc-says-trump-bodyguard-lawyer-raided-his-office-took-n870351'" tppabs="https://www.nbcnews.com/politics/donald-trump/trump-doc-says-trump-bodyguard-lawyer-raided-his-office-took-n870351" class="external text external">"Trump doctor Harold Bornstein says bodyguard, lawyer 'raided' his office, took medical files"</a>. <i>NBC News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2018</span>.</cite></span></li><li id="cite_note-95"> <span id="mw-reference-text-cite_note-95" class="mw-reference-text"><cite id="CITEREFAltman2017" class="citation news cs1">Altman LK (1 February 2017). <a href="javascript:if(confirm('https://www.nytimes.com/2017/02/01/us/politics/trump-prostate-drug-hair-harold-bornstein.html?_r=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2017/02/01/us/politics/trump-prostate-drug-hair-harold-bornstein.html?_r=0'" tppabs="https://www.nytimes.com/2017/02/01/us/politics/trump-prostate-drug-hair-harold-bornstein.html?_r=0" class="external text external">"Donald Trump's Longtime Doctor Says President Takes Hair-Growth Drug"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">25 February</span> 2017</span>.</cite></span></li><li id="cite_note-96"> <span id="mw-reference-text-cite_note-96" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.theguardian.com/us-news/2017/feb/02/trump-doctor-reveals-secret-to-presidents-healthy-head-of-hair  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.theguardian.com/us-news/2017/feb/02/trump-doctor-reveals-secret-to-presidents-healthy-head-of-hair'" tppabs="http://www.theguardian.com/us-news/2017/feb/02/trump-doctor-reveals-secret-to-presidents-healthy-head-of-hair" class="external text external">"Trump doctor reveals secret to US president's hair"</a>. <i>the Guardian</i>. 2 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">13 May</span> 2020</span>.</cite></span></li><li id="cite_note-pmid29601622-97"> <span id="mw-reference-text-cite_note-pmid29601622-97" class="mw-reference-text"><cite id="CITEREFLeeJuhaszMobasherEkelem2018" class="citation journal cs1">Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA (April 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098" class="external text external">"A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women"</a>. <i>J Drugs Dermatol</i>. <b>17</b> (4): 457–463. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609098" class="external text external">6609098</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29601622  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29601622'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29601622" class="external text external">29601622</a>.</cite></span></li><li id="cite_note-pmid31832993-98"> <span id="mw-reference-text-cite_note-pmid31832993-98" class="mw-reference-text"><cite id="CITEREFMarksPrasadDe_SouzaBurns2019" class="citation journal cs1">Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM (December 2019). "Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris". <i>Am J Clin Dermatol</i>. <b>21</b> (2): 245–254. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40257-019-00493-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40257-019-00493-z'" tppabs="https://doi.org/10.1007%2Fs40257-019-00493-z" class="external text external">10.1007/s40257-019-00493-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31832993  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31832993'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31832993" class="external text external">31832993</a>.</cite></span></li><li id="cite_note-Danby2015-99"> <span id="mw-reference-text-cite_note-Danby2015-99" class="mw-reference-text"><cite id="CITEREFF._William_Danby2015" class="citation book cs1">F. William Danby (27 January 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=Z1yFBQAAQBAJ&pg=PA147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Z1yFBQAAQBAJ&pg=PA147'" tppabs="https://books.google.com/books?id=Z1yFBQAAQBAJ&pg=PA147" class="external text external"><i>Acne: Causes and Practical Management</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>147–. ISBN<span>&nbsp;</span><bdi>978-1-118-23277-4</bdi>.</cite></span></li><li id="cite_note-pmid23431485-100"> <span id="mw-reference-text-cite_note-pmid23431485-100" class="mw-reference-text"><cite id="CITEREFMarchettiBarth2013" class="citation journal cs1">Marchetti PM, Barth JH (March 2013). "Clinical biochemistry of dihydrotestosterone". <i>Ann. Clin. Biochem</i>. <b>50</b> (Pt 2): 95–107. doi:<a href="javascript:if(confirm('https://doi.org/10.1258%2Facb.2012.012159  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1258%2Facb.2012.012159'" tppabs="https://doi.org/10.1258%2Facb.2012.012159" class="external text external">10.1258/acb.2012.012159</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23431485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23431485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23431485" class="external text external">23431485</a>.</cite></span></li><li id="cite_note-pmid30604525-101"> <span id="mw-reference-text-cite_note-pmid30604525-101" class="mw-reference-text"><cite id="CITEREFHuChapmanMesinkovska2019" class="citation journal cs1">Hu AC, Chapman LW, Mesinkovska NA (January 2019). "The efficacy and use of finasteride in women: a systematic review". <i>Int. J. Dermatol</i>. <b>58</b> (7): 759–776. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fijd.14370  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fijd.14370'" tppabs="https://doi.org/10.1111%2Fijd.14370" class="external text external">10.1111/ijd.14370</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30604525  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30604525'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30604525" class="external text external">30604525</a>.</cite></span></li><li id="cite_note-pmid19293006-102"> <span id="mw-reference-text-cite_note-pmid19293006-102" class="mw-reference-text"><cite id="CITEREFAlikhanLynchEisen2009" class="citation journal cs1">Alikhan A, Lynch PJ, Eisen DB (April 2009). "Hidradenitis suppurativa: a comprehensive review". <i>J. Am. Acad. Dermatol</i>. <b>60</b> (4): 539–61, quiz 562–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2008.11.911  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2008.11.911'" tppabs="https://doi.org/10.1016%2Fj.jaad.2008.11.911" class="external text external">10.1016/j.jaad.2008.11.911</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19293006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19293006'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19293006" class="external text external">19293006</a>.</cite></span></li><li id="cite_note-pmid28128074-103"> <span id="mw-reference-text-cite_note-pmid28128074-103" class="mw-reference-text"><cite id="CITEREFRiisRingThemstrupJemec2016" class="citation journal cs1">Riis PT, Ring HC, Themstrup L, Jemec GB (December 2016). "The Role of Androgens and Estrogens in Hidradenitis Suppurativa - A Systematic Review". <i>Acta Dermatovenerol Croat</i>. <b>24</b> (4): 239–249. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28128074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28128074'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28128074" class="external text external">28128074</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/finasteride  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/finasteride'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/finasteride" class="external text external">"Finasteride"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em">Androgens and antiandrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Androgens<br>(incl. <abbr>AAS</abbr>)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> Androstenediol dipropionate</li>
<li>Boldenone undecylenate</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a></li>
<li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li>
<li>Cloxotestosterone acetate</li>
<li>Prasterone (dehydroepiandrosterone, DHEA)</li>
<li>Prasterone enanthate (DHEA enanthate)</li>
<li>Prasterone sulfate (DHEA sulfate)</li>
<li>Quinbolone</li>
<li>Testosterone<sup>#</sup></li>
<li>Testosterone esters (e.g., testosterone cypionate, testosterone enanthate, testosterone propionate, testosterone undecanoate, testosterone ester mixtures (Deposterona, Omnadren, Sustanon, Testoviron Depot))</li></ul>

<ul><li><i>Dihydrotestosterone derivatives:</i> Androstanolone (stanolone, dihydrotestosterone, DHT)</li>
<li>Androstanolone esters</li>
<li>Bolazine capronate</li>
<li>Drostanolone propionate (dromostanolone propionate)</li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a></li>
<li>Metenolone acetate (methenolone acetate)</li>
<li>Metenolone enanthate (methenolone enanthate)</li>
<li>Stenbolone acetate</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> Bolandiol dipropionate</li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norclostebol</li>
<li>Norclostebol acetate</li>
<li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li>
<li>Trenbolone acetate</li>
<li>Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Metandienone (methandienone, methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)</li>
<li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li>
<li>Methyltestosterone 3-hexyl ether</li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone (thiomesterone)</li></ul>

<ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Mibolerone</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li>Propetandrol (propethandrol)</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li>Progestins (e.g., <a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, lynestrenol, norgestrienone)</li>
<li>Tibolone</li></ul>

<ul><li><i>Progesterone derivatives:</i> <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiestrogens (e.g., <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a>)</li>
<li>GnRH agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>, <a href="Human_chorionic_gonadotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr>hCG</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><abbr>AR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Abiraterone acetate</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Nomegestrol acetate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Apalutamide</li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Darolutamide</li>
<li>Enzalutamide</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li>Topilutamide (fluridil)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Steroidogenesis<br>inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5α-Reductase</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abiraterone acetate</li>
<li><a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li>Bifluranol</li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li>Seviteronel<sup>†</sup></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., bifluranol, <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>, estradiol esters, ethinylestradiol, ethinylestradiol sulfonate, paroxypropione)</li>
<li>GnRH agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>GnRH antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li>
<li>Progestogens (incl., chlormadinone acetate, cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Androgen receptor modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of androgens/anabolic steroids</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="font-size:114%;margin:0 4em">Drugs used in benign prostatic hyperplasia (G04C)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">5α-Reductase inhibitors</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alpha-1 blockers</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alfuzosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfuzosin" title="Alfuzosin">Alfuzosin</a></li>
<li><a href="Doxazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxazosin" title="Doxazosin">Doxazosin</a></li>
<li>Silodosin</li>
<li><a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">Tamsulosin</a></li>
<li><a href="Terazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Terazosin" title="Terazosin">Terazosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Steroidal antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Delmadinone acetate</li>
<li>Gestonorone caproate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Herbal products</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Pygeum africanum</i></li>
<li><i>Saw palmetto extract</i></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Mepartricin</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Other_dermatological_preparations_(D11)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Other_dermatological_preparations_(D11)" style="font-size:114%;margin:0 4em">Other dermatological preparations (D11)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-seborrheics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><i>Antifungals</i>
<ul><li><a href="Bifonazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Bifonazole" title="Bifonazole">Bifonazole</a></li>
<li>Cetrimonium bromide (cetrimide)</li>
<li>Ciclopirox olamine (ciclopirox)</li>
<li>Climbazole</li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Miconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Miconazole" title="Miconazole">Miconazole</a></li>
<li>Piroctone olamine</li>
<li><a href="Selenium_disulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Selenium_disulfide" title="Selenium disulfide">Selenium disulfide (selenium sulfide)</a></li>
<li><span class="new">Xenysalate</span></li>
<li><a href="Zinc_pyrithione.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc_pyrithione" title="Zinc pyrithione">Zinc pyrithione (pyrithione zinc)</a></li></ul></li>
<li><i>Antihistamines</i></li>
<li><i>Calcineurin inhibitors</i>
<ul><li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporin" title="Cyclosporin" class="mw-redirect">Cyclosporin</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li><i>Keratolytics</i>
<ul><li>Coal tar</li>
<li><a href="Resorcinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Resorcinol" title="Resorcinol">Resorcinol</a></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylic acid</a></li>
<li><a href="Sulfur.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur" title="Sulfur">Sulfur</a></li>
<li><a href="Urea.htm" tppabs="https://ptable.com/wiki/compounds/A/Urea" title="Urea">Urea</a> (urea-containing cream)</li></ul></li>
<li><i>Lithium salts</i>
<ul><li>Lithium gluconate</li>
<li>Lithium succinate</li></ul></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin lightening</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Hydroquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroquinone" title="Hydroquinone">Hydroquinone</a></li>
<li><a href="Mequinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mequinol" title="Mequinol">Mequinol</a></li>
<li><a href="Monobenzone.htm" tppabs="https://ptable.com/wiki/compounds/A/Monobenzone" title="Monobenzone">Monobenzone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin darkening</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Afamelanotide</li>
<li>Melanotan II</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-inflammatories</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxaceprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li>
<li><a href="Gamma-Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Linolenic_acid" title="Gamma-Linolenic acid">Gamolenic acid</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alopecia treatments</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5α-Reductase inhibitors</i> 
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Topilutamide (fluridil)</li></ul></li>
<li><i>Potassium channel openers</i>
<ul><li><a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">Minoxidil</a></li></ul></li>
<li><i>Others</i>
<ul><li>Nepidermin</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hair growth inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5α-Reductase inhibitors</i>
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><a href="Eflornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eflornithine" title="Eflornithine">Eflornithine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens (e.g., testosterone)</li>
<li><a href="Brimonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brimonidine" title="Brimonidine">Brimonidine</a></li>
<li><a href="Calcium_gluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a></li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>)</li>
<li>Hyaluronic acid</li>
<li><a href="Magnesium_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium_sulfate" title="Magnesium sulfate">Magnesium sulfate</a></li>
<li>Pregnenolone acetate</li>
<li>Progestogens (e.g., progesterone)</li>
<li><a href="Povidone-iodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Povidone-iodine" title="Povidone-iodine">Povidone-iodine</a></li>
<li>Tiratricol</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Merck_&amp;amp;_Co.,_Inc." style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Merck_&amp;amp;_Co.,_Inc." style="font-size:114%;margin:0 4em">Merck &amp; Co., Inc.</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Corporate directors:</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Richard Clark</li>
<li>Johnnetta Cole</li>
<li>William Harrison</li>
<li><span class="new">William Kelley</span></li>
<li>Rochelle Lazarus</li>
<li>Thomas Shenk</li>
<li><span class="new">Anne Tatlock</span></li>
<li>Samuel Thier</li>
<li>Wendell Weeks</li>
<li><span class="new">Peter Wendell</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products:</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alendronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Alendronic_acid" title="Alendronic acid">Alendronate</a></li>
<li><a href="Aprepitant.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprepitant" title="Aprepitant">Aprepitant</a></li>
<li><a href="Ertapenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Ertapenem" title="Ertapenem">Ertapenem</a></li>
<li><a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li>Ezetimibe/simvastatin</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Fosaprepitant</li>
<li><a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">Indinavir</a></li>
<li><a href="Losartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Losartan" title="Losartan">Losartan</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="Montelukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Montelukast" title="Montelukast">Montelukast</a></li>
<li>Omarigliptin</li>
<li>Raltegravir</li>
<li><a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">Rizatriptan</a></li>
<li><a href="Rofecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Rofecoxib" title="Rofecoxib">Rofecoxib</a></li>
<li>rVSV-ZEBOV vaccine</li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="Sitagliptin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sitagliptin" title="Sitagliptin">Sitagliptin</a></li>
<li><a href="Vorinostat.htm" tppabs="https://ptable.com/wiki/compounds/A/Vorinostat" title="Vorinostat">Vorinostat</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Publications:</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>The Merck Manuals
<ul><li><i>Index</i></li>
<li><i>Manual</i></li>
<li><i>Veterinary</i></li>
<li><i>Geriatrics</i></li></ul></li></ul>
</div></td></tr></tbody></table></div>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-01" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Finasteride&oldid=970564059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Finasteride&oldid=970564059'" tppabs="https://en.wikipedia.org/wiki/?title=Finasteride&oldid=970564059">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>